Correlation Between Genexine and Green Cross

Can any of the company-specific risk be diversified away by investing in both Genexine and Green Cross at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genexine and Green Cross into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genexine and Green Cross Medical, you can compare the effects of market volatilities on Genexine and Green Cross and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genexine with a short position of Green Cross. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genexine and Green Cross.

Diversification Opportunities for Genexine and Green Cross

0.5

Correlation Coefficient

Genexine  Green Cross

Very weak diversification

The 3 months correlation between Genexine and Green is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Genexine and Green Cross Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Green Cross Medical and Genexine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genexine are associated (or correlated) with Green Cross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Green Cross Medical has no effect on the direction of Genexine i.e., Genexine and Green Cross go up and down completely randomly.

Pair Corralation between Genexine and Green Cross

Assuming the 90 days trading horizon Genexine is expected to under-perform the Green Cross. But the stock apears to be less risky and, when comparing its historical volatility, Genexine is 1.18 times less risky than Green Cross. The stock trades about -0.29 of its potential returns per unit of risk. The Green Cross Medical is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  404,000  in Green Cross Medical on October 24, 2024 and sell it today you would lose (14,000) from holding Green Cross Medical or give up 3.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Genexine  vs.  Green Cross Medical

Genexine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genexine has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Green Cross Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Green Cross Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Green Cross is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Genexine and Green Cross

The main advantage of trading using opposite Genexine and Green Cross positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genexine position performs unexpectedly, Green Cross can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Cross will offset losses from the drop in Green Cross' long position.

The idea behind Genexine and Green Cross Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.